Lexicon Pharmaceuticals (NASDAQ: LXRX)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Lexicon Pharmaceuticals (NASDAQ: LXRX) through any online brokerage.
The latest price target for Lexicon Pharmaceuticals (NASDAQ: LXRX) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting LXRX to rise to within 12 months (a possible 26.18% upside). 50 analyst firms have reported ratings in the last year.
The stock price for Lexicon Pharmaceuticals (NASDAQ: LXRX) is $3.17 last updated August 12, 2022, 8:00 PM UTC.
The next Lexicon Pharmaceuticals (LXRX) dividend date is projected to be Thursday, September 1, 2022.
Lexicon Pharmaceuticals’s FY earnings are confirmed for Wednesday, December 20, 2023.
There is no upcoming split for Lexicon Pharmaceuticals.
Lexicon Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.